InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition.
With our long history in the industry, we provide more than 6,000 research and publications.
Research title with ★ indicates InBody recommended paper.

Differences in prescribed Kt/V and delivered haemodialysis dose—why obesity makes a difference to survival for haemodialysis pa

Davenport A
Used Parameters : TBW, PBF

Publication Year : 2013

Country : UK

Journal : Nephrology Dialysis Transplantation

Background Morbid obesity is reported to be a survival factor for haemodialysis patients compared with those with a normal body mass index (BMI), yet morbid obesity (BMI> 35) is a mortality risk factor for obese patients in the general population. Traditionally, haemodialysis dosing is prescribed to achieve a target Kt/V corrected for total body water (TBW). As obese patients typically have increased body fat, which contains less water than muscle, then obese patients may have lower levels of body water than their slimmer counterparts, and as …
Full text